Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting
Fernando Franco, Juan Carlos Cámara, Jose Ignacio Martin-Valades, Ana López‐Alfonso, David Marrupe, David Gutiérrez-Abad, B. Martínez-Amores, Ana León, Ignacio Juez, Marta Pérez Pérez, Ana Royuela, Ana Ruiz‐Casado
Topics & Concepts
MedicineFOLFIRINOXGemcitabineInternal medicinePancreatic cancerIncidence (geometry)Performance statusRetrospective cohort studyClinical trialGastroenterologySurgeryCancerOncologyIrinotecanColorectal cancerPhysicsOpticsPancreatic and Hepatic Oncology ResearchCancer Research and TreatmentsRenal cell carcinoma treatment